U.S. researchers found that a gene therapy helped improve the vision of 12 children suffering from a rare genetic eye condition called Leber's congenital amaurosis. The treatment involves injecting a bioengineered version of the RPE65 gene, which is enclosed in an adeno-associated virus, under the retina of the eye.

Related Summaries